Literature DB >> 5325584

Trial of amantadine in epidemic influenza.

H A Wendel, M T Snyder, S Pell.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1966        PMID: 5325584     DOI: 10.1002/cpt19667138

Source DB:  PubMed          Journal:  Clin Pharmacol Ther        ISSN: 0009-9236            Impact factor:   6.875


× No keyword cloud information.
  18 in total

Review 1.  Amantadine and rimantadine for influenza A in adults.

Authors:  T Jefferson; V Demicheli; C Di Pietrantonj; D Rivetti
Journal:  Cochrane Database Syst Rev       Date:  2006-04-19

2.  Protection of man from natural infection with influenza A2 Hong Kong virus by amantadine: a controlled field trial.

Authors:  N Oker-Blom; T Hovi; P Leinikki; T Palosuo; R Pettersson; J Suni
Journal:  Br Med J       Date:  1970-09-19

3.  Administration of amantadine for the prevention of Hong Kong influenza.

Authors:  I Nafta; A G TTurcanu; I Braun; W Companetz; A Simionescu; E Birţ; V Florea
Journal:  Bull World Health Organ       Date:  1970       Impact factor: 9.408

Review 4.  Infectious diseases. Annual review of significant publications.

Authors:  H A Reimann
Journal:  Postgrad Med J       Date:  1967-03       Impact factor: 2.401

5.  Prevention and treatment of influenza.

Authors:  C H Stuart-Harris
Journal:  Br Med J       Date:  1969-01-18

Review 6.  Amantadine and rimantadine for influenza A in children and the elderly.

Authors:  Márcia G Alves Galvão; Marilene Augusta Rocha Crispino Santos; Antonio J L Alves da Cunha
Journal:  Cochrane Database Syst Rev       Date:  2014-11-21

7.  Amantadine-HCl (Symmetrel) in the management of Parkinson's disease: a double-blind cross-over study.

Authors:  A Barbeau; H Mars; M I Botez; M Joubert
Journal:  Can Med Assoc J       Date:  1971-07-10       Impact factor: 8.262

Review 8.  Amantadine and rimantadine prophylaxis of influenza A in nursing homes. A tolerability perspective.

Authors:  D R Guay
Journal:  Drugs Aging       Date:  1994-07       Impact factor: 3.923

9.  Antimicrobial and hypoglycemic activities of novel N-Mannich bases derived from 5-(1-adamantyl)-4-substituted-1,2,4-triazoline-3-thiones.

Authors:  Ebtehal S Al-Abdullah; Hanaa M Al-Tuwaijri; Hanan M Hassan; Mogedda E Haiba; Elsayed E Habib; Ali A El-Emam
Journal:  Int J Mol Sci       Date:  2014-12-11       Impact factor: 5.923

10.  Synthesis, antimicrobial, and anti-inflammatory activity, of novel S-substituted and N-substituted 5-(1-adamantyl)-1,2,4-triazole-3-thiols.

Authors:  Ebtehal S Al-Abdullah; Hanadi H Asiri; Siham Lahsasni; Elsayed E Habib; Tarek M Ibrahim; Ali A El-Emam
Journal:  Drug Des Devel Ther       Date:  2014-05-12       Impact factor: 4.162

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.